Medwaz (0742.899.739): financials and annual accounts

Medwaz

Sint-Pieters-Leeuw ·KBO/BCE: BE 0742.899.739

Line	2025	2024	2023	2022	2021
Balance sheet: assets
Total assets`20/58`	381,592	748,444	589,945	363,432	158,373
Fixed assets`21/28`	66,099	-	-	-	-
Tangible fixed assets`22/27`	66,099	-	-	-	-
Furniture and vehicles`24`	66,099	-	-	-	-
Current assets`29/58`	315,493	748,444	589,945	363,432	158,373
Amounts receivable within one year`40/41`	28,515	401,005	257,686	193,006	38,367
Other amounts receivable`41`	28,515	401,005	257,686	193,006	38,367
Cash at bank and in hand`54/58`	286,977	347,438	332,258	170,426	120,006
Balance sheet: equity and liabilities
Total equity and liabilities`10/49`	381,592	748,444	589,945	363,432	158,373
Equity`10/15`	4,000	483,317	488,798	322,420	158,373
Contributions`10/11`	4,000	4,000	4,000	4,000	4,000
Capital`10`	4,000	4,000	4,000	4,000	4,000
Issued capital`100`	4,000	4,000	4,000	4,000	4,000
Profit (loss) carried forward`14`	-	479,317	484,798	318,420	154,373
Amounts payable`17/49`	377,592	265,127	101,146	41,012	-
Amounts payable within one year`42/48`	377,592	265,127	101,146	41,012	-
Taxes, remuneration and social security`45`	-	83,290	101,146	41,012	-
Taxes`450/3`	-	83,290	101,146	41,012	-
Other amounts payable`47/48`	377,592	181,836	-	-	-
Income statement
Gross operating margin`9900`	192,707	185,202	248,558	192,317	154,348
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets`630`	9,345	-	-	-	-
Other operating charges`640/8`	-	184	-	-	1,089
Operating profit (loss)`9901`	183,362	185,018	248,558	192,317	153,259
Financial income`75/76B`	-	19,999	11,939	12,862	1,204
Recurring financial income`75`	-	19,999	11,939	12,862	1,204
Financial charges`65/66B`	167	144	122	120	90
Recurring financial charges`65`	167	144	122	120	90
Profit (loss) for the period before taxes`9903`	183,195	204,874	260,375	205,059	154,373
Income taxes`67/77`	42,028	55,982	93,996	41,012	-
Profit (loss) for the period`9904`	141,167	148,891	166,379	164,047	154,373
Profit (loss) for the period to be appropriated`9905`	141,167	148,891	166,379	164,047	154,373
Appropriation of the result
Profit (loss) to be appropriated`9906`	620,485	633,689	484,798	318,420	154,373
Profit (loss) brought forward from the previous period`14P`	479,317	484,798	318,419	154,373	-
Profit to be distributed`694/7`	620,485	154,372	-	-	-
Return on contributions (dividend)`694`	620,485	154,372	-	-	-
Document	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
31-12-2025	abbreviated format	28-08-2026	2026-00446222	PDF
31-12-2024	micro format	28-08-2025	2025-00421936	PDF
31-12-2023	micro format	30-09-2024	2024-00488345	PDF
31-12-2022	micro format	01-09-2023	2023-00407434	PDF
31-12-2021	micro format	19-08-2022	2022-20296409	PDF

Line	2025	2024	2023	2022	2021
EBITDA	192,707	-	-	-	-
Cash flow	150,513	-	-	-	-
Investment in fixed assets	75,444	-	-	-	-
Change in cash	-60,461	15,180	161,832	50,420	-
Working capital	-62,099	483,317	488,798	322,420	-
Solvency	1.0%	64.6%	82.9%	88.7%	100.0%
Current ratio	0.84	2.82	5.83	8.86	-
Debt to equity	94.40	0.55	0.21	0.13	-
ROE	-	30.8%	34.0%	50.9%	97.5%
ROA	37.0%	19.9%	28.2%	45.1%	97.5%
Interest coverage	over 100	-	-	-	-

Item	2025	2024	2023	2022	2021
Tangible fixed assets	€75,444	-	-	-	-
Depreciation and write-downs of the year	€9,345	-	-	-	-

Medwaz

Annual accounts 2025

Balance sheet

Change in equityin euro

Change in cashin euro

Filed annual accounts

Filings

Key figures and ratios

Investments

Insights on Medwaz

Next steps